English 
中文 
Bahasa Melayu 
Bahasa Indonesia The cell industry is blooming like thousands of pear trees in spring, signaling a transformative shift as it approaches a trillion-yuan market value. Cell medicine is opening the door to the future of human health care.
Cell Medicine Enters a New Spring
To advance the development of cell medicine, the World Chinese Elites Union (WCEU) Chairperson Guan Bihong convened industry, academic, and research leaders on December 24, 2023, at the Xinnuo Sai Biotechnology Co., Ltd. in Ningbo, Zhejiang. The meeting marked the establishment of the Elite Committee’s Cell Medicine Special Committee. Dr. Zhang Hongkai, a pioneer in cell medicine, was appointed as the Chair, with Dr. Wei Qiming, an academician in cardiovascular and thoracic sciences and Executive Director of the Zhongguancun Stem Cell Research Institute, serving as President. Huang Yingzhi, Chairman of Ningbo Dayi Cell Therapy, was appointed as Executive Vice President, among other key roles.
Leadership Figures:
Prof. Zhang Hongkai
President of the International Cell Rehabilitation Association
Chairman Guan Bihong
President of the World Chinese Elites Union
Academician Wei Qiming
International Cell Rehabilitation Association Vice President
On January 3, 2024, Guan Bihong published an article titled "Living to 125 Years Is Not a Dream—A Record of Prof. Zhang Hongkai, the Founder of Cell Medicine" simultaneously in several media outlets, including the American Chinese Business Journal, American Chinese Network, American News Network, European News Network, and European Chinese Network. The article generated significant attention. It quoted Prof. Zhang Hongkai's statement that "humans only suffer from one disease, which is 'cell disease,'" and predicted that the focus of 21st-century medical research would inevitably shift to "cells." Cell medicine is expected to become the mainstream of future medicine, with chronic disease treatments being dominated by cell medicine. The arrival of cell medicine will truly usher humanity into a new era of medicine.
To further promote the development of cell medicine, Guan Bihong also convened nearly forty industry leaders, including Wang Siyuan, founder of Shenzhen Cell Bank, Li Lingxi, Chairman of Tianjin Jinximeng Stem Cell, and Tian Jun, former Deputy Director of the Armed Police Heart Hospital, for the Ninth Standing Committee of the Elite Society held at the Ningbo and Zhoushan Cell Experience Center. The meeting reviewed cell anti-aging and beauty treatments and released a promotional video for the "Cell Medicine Development Strategy."
From February 25 to March 12, Guan Bihong and Zhang Hongkai conducted inspections in Hainan, Guangxi, Yunnan, and Guangdong provinces and cities to finalize the operational points for the "Zhang Hongkai Cell Medicine Center" cell hospitals in Hainan, Guangxi, and Yunnan. On March 3, they established the "International Cell Rehabilitation Association Yunnan Branch" in Kunming, the Spring City.
On March 10, Liu Xiangli, Chairman of Lizkar, invited Prof. Zhang Hongkai to present over ten of his developed cell medicine products at the Guangzhou Beauty Expo. Currently, the number of clinical trial applications for stem cell drugs is steadily increasing, from 5 applications in 2018 to 47 in 2023, nearly doubling from 2022, indicating a very positive trend. If you want to learn about the current state of cell medicine development, please join the "Cell Medicine Group" or call the President of the International Cell Rehabilitation Association, Guan Bihong, at 18925277931.
